Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topical diltiazem for chronic anal fissure
ACTRN12607000616471Phase 2Terminated
- Sponsor
- SLA Pharma
- Start
- Jan 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised trial in anal fissure comparing Diltiazem hydrochloride cream with Placebo cream (2 arms). Primary endpoint: Pain on defaecation relief at Week 8. Started Jan 2008; status: terminated.
02
Drugs
diltiazem
03
Conditions
anal fissure
Beyond the preview
Go deeper on ACTRN12607000616471.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12607000616471.